Clinical Trial Detail

NCT ID NCT00588770
Title Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

head and neck squamous cell carcinoma

Therapies

Bevacizumab

Cisplatin + Docetaxel

Cisplatin + Fluorouracil

Carboplatin + Docetaxel

Carboplatin + Fluorouracil

Age Groups: adult

No variant requirements are available.